Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Ecological Research & Development Group (ERDG) is a non-profit organization primarily focused on the conservation of the world’s four horseshoe crab species. While an environmental group, ERDG is a critical stakeholder in the life sciences industry because horseshoe crab blood is the sole source of Limulus Amebocyte Lysate (LAL), a reagent required by the FDA for endotoxin testing in all injectable drugs and implantable medical devices. The organization works closely with the biomedical industry to promote sustainable harvesting practices and the protection of spawning habitats to ensure the long-term viability of this essential medical resource. ERDG also facilitates international collaboration between conservationists and the pharmaceutical industry to balance ecological health with global healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecological Research & Development Group.